AQR Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Buy |
1,238,393
+585,116
| +90% | +$1.99M | ﹤0.01% | 1381 |
|
|
2025
Q1 | $2.62M | Buy |
653,277
+521,135
| +394% | +$2.09M | ﹤0.01% | 1467 |
|
|
2024
Q4 | $858K | Buy |
132,142
+52,236
| +65% | +$339K | ﹤0.01% | 1969 |
|
|
2024
Q3 | $443K | Buy |
79,906
+19,759
| +33% | +$109K | ﹤0.01% | 2229 |
|
|
2024
Q2 | $336K | Buy |
60,147
+40,240
| +202% | +$225K | ﹤0.01% | 2220 |
|
|
2024
Q1 | $134K | Sell |
19,907
-36,299
| -65% | -$244K | ﹤0.01% | 2310 |
|
|
2023
Q4 | $513K | Buy |
56,206
+17,167
| +44% | +$157K | ﹤0.01% | 1874 |
|
|
2023
Q3 | $215K | Buy |
39,039
+13,057
| +50% | +$72.1K | ﹤0.01% | 2119 |
|
|
2023
Q2 | $222K | Buy |
+25,982
| New | +$222K | ﹤0.01% | 2057 |
|
|
2022
Q4 | – | Sell |
-31,163
| Closed | -$459K | – | 2214 |
|
|
2022
Q3 | $459K | Buy |
+31,163
| New | +$459K | ﹤0.01% | 1821 |
|